New Clinical Study On Attention and Memory In People With MS
A major trial to investigate different ways to deal with attention and memory problems in multiple sclerosis (MS) patients…
Articles by Patricia Silva, PhD
Online Neurology Resource Platform Launches Recent MS Research Findings
The online community for neurologists Neurology Times will feature special coverage focused on multiple sclerosis…
Researchers Develop First Accurate Method to Assess Important Protein in MS, Other Diseases
Researchers at the University of Copenhagen and Rigshospitalet in Denmark have for the first time developed an…
Multiple Sclerosis Eye Care Center Commemorates 10-Year Anniversary
The Multiple Sclerosis Eye Center for Analysis, Research and Education (MS Eye CARE) is celebrating 10 years of expert eye care…
Hypertension Medication Found to Offer Protective Effect Against Multiple Sclerosis Symptoms in Mice
A new study recently published in the journal Nature Communications led by researchers at The University…
Researchers Identify a New Genetic Risk Factor for Multiple Sclerosis Development
A team led by researchers from the University of Illinois at Chicago (UIC) recently revealed in the journal…
Women with Multiple Sclerosis May Have Lower Levels of Anti-Inflammatory Antioxidants And Nutrients
Compared to healthy people, women with multiple sclerosis (MS) may have inferior levels of certain antioxidants and nutrients with…
Translational Medicine Consortium Grants $1.9 Million for MS Research
The Strategic Pharma-Academic Research Consortium for Translational Medicine has awarded its first grants totaling more than $1.9 million to support research…
Spinal Cord Alteration in Multiple Sclerosis Could Lead to New Therapeutic Target
A recent study led by researchers at the Centre for Addiction and Mental Health (CAMH) in…
National MS Society Now Sponsored by Key Bike MS Supporter
The National Multiple Sclerosis Society will receive an annual sponsorship from Showers Pass to support its efforts to improve the quality…
Accelerated Cure Project to Increase Participation in MS Trials
Nonprofit organization, Accelerated Cure Project for Multiple Sclerosis, is launching a national campaign called iConquerMS, which was…
Scientists Update Recommendations on MS Research
Several renowned scientists working on multiple sclerosis (MS) recently joined forces to discuss and highlight the…
Creative Medical Seeks Patent for Stem Cell Therapy for MS
Phoenix, Arizona-based Creative Medical Health (CMH) has just announced it has submitted a patent application for its…
Novel Antibody Drug Candidate From Chinese Drug Developer Shows Promise For Treating MS
MicroConstants China, Inc., a company that provides preclinical, clinical, and consulting services to biotechnology and pharmaceutical companies, has just announced…
Phase I Clinical Studies To Begin Using Anatabine Citrate as Possible Therapy For MS
Drug development company Rock Creek Pharmaceuticals, Inc. recently announced that a new clinical trial application with the United Kingdom’s Medicines Healthcare Products…
Helicobacter Pylori Infection May Help Protect Against Multiple Sclerosis in Females
A new study on the association between Helicobacter pylori and multiple sclerosis (MS) entitled “Helicobacter pylori…
MS Inspiration Offers Sports Tickets on Campaign with Tyler Campbell and Chris Wright
Tyler Campbell, the son of the NFL Hall of Famer Earl Campbell, and professional basketball player Chris Wright are…
Multiple Sclerosis Association of America Partners With Local Businesses To Raise Funds, Awareness
Total Fitness Club (TFC), a private, employee-owned fitness company based in Swansea, Massachusetts recently announced the top placers of…
MuckFest MS Recently Featured on ABC’s “The Bachelor”
The fundraising event MuckFest MS, which takes place this year between April and November in 11 different cities across the U.S.
US Supreme Court Rules on Teva Pharma’s Copaxone Patent Case
Teva Pharmaceutical Industries Ltd. recently made a major announcement on the U.S. Supreme Court‘s…
Kessler Foundation Study Says Cognitive Fatigue in Multiple Sclerosis Depends on Task Length
A study from a team of researchers at the Kessler Foundation provides new findings on multiple sclerosis (MS).
Stem Cell Transplantation May Improve Disability in Patients with Multiple Sclerosis
A new research study indicates that in patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hematopoietic stem…
Receptos Launches SUNBEAM Phase 3 Trial for Relapsing Multiple Sclerosis Therapy
Biopharmaceutical company Receptos, Inc. has enrolled the first participant with relapsing multiple sclerosis (RMS) in its…
Amarantus Acquires DioGenix to Bolster New MS Diagnostic Division
Amarantus BioScience Holdings, Inc. has announced the acquisition of DioGenix, Inc., which will be merged as a new foundational asset into a growing…
MedDay Provides Update on Pipeline Progress for Primary & Secondary Progressive Multiple Sclerosis Drug
MedDay, a biotechnology company that develops new drugs for nervous system disorders, announced an update on the progress of…
Arena Announces Encouraging MS-related Results from Autoimmune Therapy Trial
Arena Pharmaceuticals, Inc. released the first results from its phase 1b trial that for the evaluation of an oral drug candidate…
Researchers Study Device to Improve Balance for MS Patients
Multiple sclerosis (MS) patients often experience difficulty with balance and fear falling, which may prevent them from being…
Plegridy for Relapsing MS Now Approved in Scotland
The Scottish Medicines Consortium has just approved Biogen Idec’s Plegridy (peg interferon beta-1a) for the treatment of…
National Multiple Sclerosis Society Funds Bionure’s Optic Neuritis Treatment Research
California-based, late-preclinical stage pharmaceutical company, Bionure, Inc,. has just announced it has signed a Sponsored Research Agreement with the National…
RRMS Study Using MRI Reveals Benefits of Experimental Therapy in Achieving No Evidence of Disease Activity
Results from a Phase 3 clinical trial entitled “AVANCE” revealed promising clinical outcomes in patients with relapsing-remitting multiple sclerosis treated…